Driven to Deliver

Combining our ability to develop and commercialize innovative medical products coupled with the capabilities of major cancer research, we are committed to developing new therapeutics for adult and pediatric patients with rare cancers.

Our Approach

Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. We have three investigational oncology programs in development for areas of high unmet medical need: QN-302, Pan-RAS, and QN-247.

More About Us

Our Therapeutics Pipeline

Our therapeutics pipeline includes cancer drug programs such as QN-302, Pan-RAS and QN-247.

Select a Drug Program to Learn More

Indication	Stage